Switch to:
GuruFocus has detected 4 Warning Signs with Horizon Pharma PLC $HZNP.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Horizon Pharma PLC (NAS:HZNP)
EV-to-EBITDA
200.74 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Horizon Pharma PLC's enterprise value is $3,479.2 Mil. Horizon Pharma PLC's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2017 was $17.3 Mil. Therefore, Horizon Pharma PLC's EV/EBITDA ratio for today is 200.74.

HZNP' s EV-to-EBITDA Range Over the Past 10 Years
Min: -608   Max: 518
Current: 200.75

-608
518

During the past 9 years, the highest EV/EBITDA Ratio of Horizon Pharma PLC was 518.00. The lowest was -608.00. And the median was -0.10.

HZNP's EV-to-EBITDA is ranked lower than
97% of the 587 Companies
in the Global Drug Manufacturers - Specialty & Generic industry.

( Industry Median: 17.50 vs. HZNP: 200.75 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Horizon Pharma PLC's stock price is $13.48. Horizon Pharma PLC's earnings per share for the trailing twelve months (TTM) ended in Mar. 2017 was $-1.32. Therefore, Horizon Pharma PLC's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Horizon Pharma PLC's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=3479.211/17.332
=200.74

Horizon Pharma PLC's current Enterprise Value is $3,479.2 Mil.
Horizon Pharma PLC's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2017 was 83.35 (Jun. 2016 ) + 30.618 (Sep. 2016 ) + -62.736 (Dec. 2016 ) + -33.9 (Mar. 2017 ) = $17.3 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Horizon Pharma PLC's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=13.48/-1.32
=

Horizon Pharma PLC's share price for today is $13.48.
Horizon Pharma PLC's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2017 was 0.09 (Jun. 2016 ) + -0.04 (Sep. 2016 ) + -0.81 (Dec. 2016 ) + -0.56 (Mar. 2017 ) = $-1.32.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Horizon Pharma PLC Annual Data

Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
ev2ebitda 0.000.000.000.00-0.69-1.21-15.9267.6219.2952.41

Horizon Pharma PLC Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
ev2ebitda 67.6279.81140.4026.4419.2917.5412.1016.0252.41212.65
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK